Affiliation:
1. Department of Endocrinology, Diabetes and Isotope Therapy, Students Research Association, Wroclaw Medical University, Pasteura Bank 4, 50-367 Wroclaw, Poland
2. Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wrocław Medical University, Pasteura Bank 4, 50-367 Wroclaw, Poland
Abstract
It is important to acknowledge the impact that COVID-19 has on the thyroid gland and how the thyroid gland status before and during infection affects SARS-CoV-2 severity. To this day those dependencies are not fully understood. It is known that the virus uses angiotensin-converting enzyme-2 as the receptor for cellular entry and it can lead to multiple organ failures due to a cytokine storm. Levels of proinflammatory molecules (such as cytokines and chemokines) which are commonly elevated during infection were significantly higher in observed SARS-CoV-2-positive patients. In terms of hypothyroidism, hyperthyroidism, and autoimmune thyroid diseases, there is no proof that those dysfunctions have a direct impact on the more severe courses of COVID-19. Regarding hyper- and hypothyroidism there was no consequential dependency between the frequency of SARS-CoV-2 infection morbidity and more severe post-infectious complications. When it comes to autoimmune thyroid diseases, more evaluation has to be performed due to the unclear relation with the level of antibodies commonly checked in those illnesses and its binding with the mentioned before virus. Nonetheless, based on analyzed works we found that COVID-19 can trigger the immune system and cause its hyperactivity, sometimes leading to the new onset of autoimmune disorders. We also noticed more acute SARS-CoV-2 courses in patients with mainly reduced free triiodothyronine serum levels, which in the future, might be used as a mortality indicating factor regarding SARS-CoV-2-positive patients. Considering subacute thyroiditis (SAT), no statistically important data proving its direct correlation with COVID-19 infection has been found. Nevertheless, taking into account the fact that SAT is triggered by respiratory tract viral infections, it might be that SARS-CoV-2 can cause it too. There are many heterogenous figures in the symptoms, annual morbidity distribution, and frequency of new cases, so this topic requires further evaluation.
Funder
Statutory Activities by the Minister of Science and Higher Education
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference77 articles.
1. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV;Agarwal;J. Postgrad. Med.,2020
2. COVID-19 and Thyroid Diseases: How the Pandemic Situation Affects Thyroid Disease Patients?;Pramono;J. ASEAN Fed. Endocr. Soc.,2020
3. (2022, July 20). WHO—Coronavirus Disease (COVID-19) Pandemic. Available online: https://covid19.who.int/table.
4. COVID-19 and thyroid infection: Learning the lessons of the past;Jadali;Acta Endocrinol.,2020
5. Low free-T3 serum levels and prognosis of COVID-19: Systematic review and meta-analysis;Llamas;Clin. Chem. Lab. Med.,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献